Related references
Note: Only part of the references are listed.A reversible coma after oxaliplatin administration suggests a pathogenetic role of electrolyte imbalance
Michele Basso et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Interactions of N-terminal and C-terminal parts of the small conductance Ca2+ activated K+ channel, hSK3
Eva Frei et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2006)
Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels
RG Webster et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
An apamin- and scyllatoxin-insensitive isoform of the human SK3 channel
OH Wittekindt et al.
MOLECULAR PHARMACOLOGY (2004)
Oxaliplatin-induced neurotoxicity: Acute hyperexcitability and chronic neuropathy
RJ Lehky et al.
MUSCLE & NERVE (2004)
Mechanism of action of voltage-gated K+ channel antibodies in acquired neuromyotonia
H Tomimitsu et al.
ANNALS OF NEUROLOGY (2004)
The K+ channel iKCA1 potentiates Ca2+ influx and degranulation in human lung mast cells
SM Duffy et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
A Randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
RM Goldberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Expression and distribution of a small-conductance calcium-activated potassium channel (SK3) protein in skeletal muscles from myotonic muscular dystrophy patients and congenital myotonic mice
T Kimura et al.
NEUROSCIENCE LETTERS (2003)
Clinical aspects and molecular basis of oxaliplatin neurotoxicity: Current management and development of preventive measures
E Gamelin et al.
SEMINARS IN ONCOLOGY (2002)
Oxaliplatin-related side effects: Characteristics and management
J Cassidy et al.
SEMINARS IN ONCOLOGY (2002)
Phenotypic variants of autoimmune peripheral nerve hyperexcitability
Ian K. Hart et al.
BRAIN (2002)
Acute oxaliplatin-induced peripheral nerve hyperexcitability
RH Wilson et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kinetics on rat sensory neurons
H Adelsberger et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Oxaliplatin - A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies
CR Culy et al.
DRUGS (2000)
Share Paper
